BSE filing, NSE: LAXMIDENTL. Summary written from the filing by ALFA Finder's alert engine.
Laxmi Dental Ltd: key numbers
- Share price
- ₹188.71
- Market cap
- ₹1,038 Cr
- Revenue (annual)
- ₹277.9 Cr
- Net profit (annual)
- ₹28.98 Cr
- P/E (TTM)
- 32.1×Sector 54.5×
- Promoter holding
- 41.75%-0.05% QoQ
- FII holding
- 6.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Laxmi Dental Ltd
All →Laxmi Dental Earnings Call Transcript: Key Takeaways
Laxmi Dental reported record quarterly revenue driven by international expansion and digital adoption.
Laxmi Dental Results Update
Laxmi Dental posted record Q2FY27 revenue of Rs 795.2 million, with EBITDA up 38.5% year-on-year. Its consolidated PAT after JV share stood at Rs 100.4 million.
Laxmi Dental Investor Presentation: Key Takeaways
Q2FY27 revenue ₹79.5 Cr (+10% YoY), a record quarter. EBITDA margin 19.2%, PAT ₹10.0 Cr (+17.6%). H1FY27 revenue ₹154.2 Cr (+11.9%).
Laxmi Dental Q2 FY27 Results: Net Profit ₹10 Cr, Up 17.6% YoY
Laxmi Dental Ltd reported revenue from operations of ₹79.5 Cr (+10.0% YoY) and net profit of ₹10 Cr (+17.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹10 Cr · +17.6% YoY
Laxmi Dental Board Meeting Date
Laxmi Dental scheduled a board meeting for November 3, 2026, to consider unaudited Q1 FY27 financial results. No financial figures are disclosed in this prior intimation.
Laxmi Dental Merger & Restructuring
Laxmi Dental Limited announced the incorporation of Leelaben Foundation, a Section 8 company, in which the company is a member, as previously approved by its board.
Other business update announcements
All →Northern Arc Capital Business Update
Northern Arc's subsidiary reached a first close of over ₹400 Crore for its Diversified Debt Fund. The India Impact Fund matured with a 14.59% gross XIRR.
- Value
- ₹400.0 Cr
Cupid Business Update
Cupid Limited entered an exclusive long-term retail arrangement with V2 Retail, securing dedicated space across 425+ stores. Management targets about ₹400 crore incremental revenue within a year.
- Execution
- Long-term arrangement; nationwide product availability targeted by mid-December 2026; revenue expectation within 12 months
Ugro Capital Business Update
UGRO Capital released a social impact study showing 58% of borrowers saw revenue growth after loans. The study was independently conducted with Impactree.
MPS Business Update
MPS Limited's Chairman and CEO, Rahul Arora, participated in a media interaction with CNBC-TV18. The discussion covered Q2FY27 financial results, business performance, and growth outlook.
Exicom Tele-Systems Business Update
Exicom Tele-Systems is consolidating manufacturing by transitioning operations from its Gurugram facility to existing plants in Hyderabad and Solan. The transition aims to optimize infrastructure and is expected to finish by November 15, 2026.
- Execution
- November 15, 2026
Kwality Pharmaceuticals Business Update
Kwality Pharmaceuticals secured EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities. This expands its EU-approved manufacturing footprint and positions it for global licensing opportunities.